BioNTech SE (ADR)

General ticker "BNTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $25.8B (TTM average)

BioNTech SE (ADR) follows the US Stock Market performance with the rate: 16.3%.

Estimated limits based on current volatility of 1.9%: low 106.27$, high 110.41$

Factors to consider:

  • Total employees count: 1310 as of 2019
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [69.71$, 130.05$]
  • 2025-12-31 to 2026-12-31 estimated range: [64.96$, 122.70$]

Financial Metrics affecting the BNTX estimates:

  • Negative: with PPE of -37.3 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of -0.53 <= 0
  • Positive: Shareholder equity ratio, % of 86.16 > 64.17
  • Positive: -14.19 < Investing cash flow per share per price, % of -7.97

Similar symbols

Short-term BNTX quotes

Long-term BNTX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue €3,819.00MM €2,751.10MM
Operating Expenses €3,128.60MM €4,065.40MM
Operating Income €690.40MM €-1,314.30MM
Non-Operating Income €495.70MM €636.60MM
Interest Expense €7.76MM €13.16MM
R&D Expense €1,783.10MM €2,254.20MM
Income(Loss) €1,186.10MM €-677.70MM
Profit(Loss)* €930.30MM €-665.30MM
Stockholders Equity €20,245.90MM €19,411.10MM
Inventory €357.70MM €283.30MM
Assets €23,006.30MM €22,529.70MM
Operating Cash Flow €5,371.40MM €207.70MM
Capital expenditure €705.50MM €452.30MM
Investing Cash Flow €-6,954.50MM €-2,081.20MM
Financing Cash Flow €-778.60MM €-45.90MM
Earnings Per Share** €3.87 €-2.77
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.